• Immunicom Presents Promising Preliminary Data from Multiple Studies in Late-Stage Cancer Patients at ISFA / E-ISFA Conference

    10 days ago - By San Diego Biotechnology

    SAN DIEGO-- biotech-Immunicom, Inc., a clinical-stage biotechnology company pioneering “subtractive” advanced cancer therapies, presented promising preliminary data from trials investigating ImmunopheresisTM therapy for metastatic, refractory, solid tumor cancer patients who previously failed multiple lines of therapy. The results presented by Immunicom's Chief Medical Officer, Dr. Robert Segal, at the...
    Read more ...

     

  • Biostatistician II - CTI Clinical Trial Services, Inc - San Diego, CA

    11 days ago - By San Diego Biotechnology

    Represent Biostatistics on CTI study teams, report study status to Biostatistics management, and perform or assist all Biostatistics-related activities while...From CTI Clinical Trial Services, Inc - Fri, 30 Apr 2021 11:09:39 GMT - View all San Diego, CA......
    Read more ...